|
Indian Pediatr 2009;46: 797-796 |
|
Significance of C-reactive Protein During
Febrile Neutropenia in Pediatric Malignancies |
K Shreedhara Avabratha, ATK Rau, P Venkataravanamma and *Aarathi Rau
From the Departments of Pediatrics and *Pathology,
Kasturba Medical College, Mangalore, India.
Correspondence to: Dr ATK Rau, Prof and Unit Chief,
Department of Pediatrics, Kasturba Medical College Hospital, Attavar,
Mangalore 575 001, Karnataka, India.
Email: [email protected]
Manuscript received: March 14, 2008;
Initial Review : April 10, 2008;
Accepted: August 27, 2008.
Published online 2009 April 1.
PII:S097475790800159-2
|
Abstract
Fifty episodes of febrile neutropenia (FN) in 33
children with malignancies were studied to evaluate the usefulness of
C-reactive protein (CRP) levels as an indicator of infection, and the
efficacy of antibiotic therapy. Nineteen FN episodes occurred in
children with documented infection whereas, 9 and 22 episodes occurred
with probable infection and fever of unknown origin, respectively. CRP
positivity during episodes of documented and probable infection was
significantly higher than with febrile episodes of unknown origin. Blood
culture was positive in 15 episodes; of these, CRP was positive in 11.
CRP declined to normal on 7th day of antibiotic therapy. CRP is a useful
indicator of infection in neutropenic children and also in determining
the efficacy of antibiotic therapy.
Keywords: C-reactive protein, Child, Febrile neutropenia,
Infection, Neoplasm.
|
Diagnosis of potentially life threatening
febrile neutropenia (FN) in pediatric malignancies is often missed or
delayed. C-reactive protein (CRP), an acute phase reactant, synthesized by
the liver during infection and acute inflammation, has been widely used as
an indicator of infection(1). However, its role as an indicator of sepsis
in immunocompromised patients has not been adequately studied. This study
was undertaken to evaluate the usefulness of CRP as an indicator of covert
infection in neutropenic children and in determining the efficacy of
antibiotic therapy.
Methods
This is a prospective study of 50 consecutive episodes
of febrile neutropenia (FN) in children suffering from malignancies and
undergoing therapy in a pediatric oncology unit of a teaching hospital.
Children between 1-15 years of age with marrow/biopsy evidence of
malignancy and clinical features of FN were included. Those with liver
disease were excluded from the study.
The diagnosis of FN was made as per standard
criteria(2) i.e. absolute neutrophil count (ANC) of <500/cmm or a
count of <1000/cmm with a predicted decline to 500/cmm, with single oral
temperature of ³38.3ºC
or a temperature of ³38°C
for ³1
hour. All participants were subjected to thorough clinical examination and
tests for hemoglobin, complete blood cell count, peripheral smear, blood
culture and sensitivity, and CRP estimation (Humatex human CRP test kit, a
latex agglutination slide test on undiluted serum). Antibiotics were then
started. CRP estimation was repeated on day 7 and on the last day of
antibiotic therapy, if extended. A value above 6 mg/L was considered
positive.
The results of CRP were compared and associated with
clinical findings and other laboratory results. SPSS version 11.5 was used
for statistical analysis.
Results
Fifty episodes of FN occurred in 33 children, 17 of
whom were males, with a mean age of 6.9 years. Thirty episodes of FN
occurred in the intensive and 20 in the maintenance phases of
chemotherapy. The commonest diagnosis was acute lymphoblastic leu-kemia
(34 episodes in 24 patients).
Out of the 50 episodes of FN, 19 (38%) occurred in
children with documented infection with clinical and/or radiological
evidence of infection and culture positivity (Group I). In these,
respiratory tract infections were the commonest (31.6%) followed by
urinary tract infections (26.3%) and sepsis (21%). Cellulitis purely on
clinical evidence was also included in this group. Nine episodes (18%)
occurred in children with probable infection (Group II), in which there
was an identifiable site of infection without a positive culture. The rest
22 (44%), were labeled as having fever of unknown origin (Group III).
ANC at presentation was <200/cmm in 19 epi-sodes (38%),
between 200-500/cmm in 17 episodes (34%) and >500/cmm in 14 episodes
(28%). A majority of the documented and probable infection, occurred with
ANC <200/cmm (73.7% and 55.6% respectively) while only a few episodes of
documented and probable infection, occurred in children with ANC >500/cmm
(10.5% and 22.2% respectively). Fifteen episodes grew organisms from
tissue fluid cultures (S. aureus: 4; P. aeuruginosa: 3;
Citrobacter: 1; E.coli: 4; S. pneumoniae: 2; and other:
1). CRP was positive in 11 of these episodes (Table I).
TABLE I
Culture Results in Febrile Neutropenia and CRP Positivity
Organism isolated |
ANC <200/cmm (n =8) |
ANC 200-500/cmm (n=5) |
ANC >500/cmm (n = 2) |
|
CRP+ve |
CRP-ve |
CRP+ve |
CRP-ve |
CRP+ve |
CRP-ve |
Staphylococcus aureus (n=4) |
2 |
0 |
2 |
0 |
0 |
0 |
Pseudomonas aeruginosa (n=3) |
1 |
1 |
1 |
0 |
0 |
0 |
Citrobacter species (n=1) |
0 |
0 |
0 |
1 |
0 |
0 |
E. coli (n=4) |
0 |
2 |
0 |
0 |
2 |
0 |
Genus bacillus (n=1) |
0 |
0 |
1 |
0 |
0 |
0 |
S. pneumoniae (n=2) |
2 |
0 |
0 |
0 |
0 |
0 |
Initial CRP positivity in the study groups revealed
that while Group I (D1:15/19; D7:4/19) and II (D1:7/9; D7:2/9) had higher
number of CRP positivity, Group I values, when considered in isolation,
were significantly higher (P<0.001). In Group III, CRP was positive
on D1 in 5/22 episodes and in 2/22 episodes on day 7. When CRP positivity
in the various groups were analyzed on day 7 and at the end of antibiotic
therapy (if later), it was found that in all three groups, CRP decreased
as treatment progressed and the child responded to therapy.
Discussion
Our findings corroborate the results of previous
studies(3,4). However, Bodey, et al.(5) demonstrated 53% documented
infections in their series, in contrast to the present study. This could
be due to low culture yields, early initiation of empirical antibiotic
therapy or better nursing care in our patients.
Of the 50 episodes of FN, true positives (i.e.
CRP positive with documented infections) accounted for 15 episodes, false
positive (i.e. CRP positive but cultures negative ) in 12, false
negative (i.e. CRP negative and culture positive) in 4 and true
negative (i.e. CRP and culture negative) in remaining 19 episodes.
The sensitivity was 55% and specificity 82% with a positive predictive
value of 78%. Putto, et al.(6) have reported a sensitivity of 100%
and specificity of 75% for CRP in infections while Peltola and Jaakkola(7)
reported a sensitivity of 89% and specificity of 77% with a positive
predictive value of 79%.
In Group I, CRP remained high in 4 children out of 15
on day 7 and on the last day of antibiotic therapy. Of these 2 died and 2
required augmentation of therapy. Other than these, in all 3 groups, CRP
positivity uniformly decreased as the children improved. Thus, CRP can
indicate persistent infection in children with FN. This correlates well
with other studies(8,9). Though there are reports of procalcitonin(PCT)
being a better marker of infection in FN, it is expensive and not readily
available(10). In a pediatric study(11) involving 60 febrile episodes,
periodic measurement of PCT was found to be more useful than CRP. However,
both PCT and CRP levels were significantly higher in FN than in controls.
We conclude that, CRP is an easily available and
significantly sensitive test to diagnose infection and monitor response to
therapy in FN.
Contributors: ATK conceived the idea, provided the
study design and stands as guarantor. Data was collected and analyzed by
VP along with ATK and KSA. KSA, ATK and AR wrote the paper. The final
manuscript was approved by all authors.
Funding: None.
Competing interests: None stated.
What This Study Adds?
• Serial estimation of C-reactive protein can
serve as a tool for diagnosing infection and monitoring the response
to antibiotic therapy in febrile neutropenia.
|
References
1. Schofield KP ,Voulgari F , Gozzard DI, Leyland MJ,
Beeching NJ. C-reactive protein concentration as a guide to antibiotic
therapy in acute leukemia. J Clin Pathol 1982; 35: 866-869.
2. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Calandra
T, Feld R, et al. 2002 guidelines for the use of antimicrobial
agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34:
730-751.
3. Nachmann JB, Honig GR. Fever and neutropenia in
children with neoplastic disease. Cancer 1980; 45: 407-412.
4. Bloomfield CD, Kennedy BJ. Cephalothin,
carbenicillin and gentamicin combination therapy for febrile patient with
acute non lymphocytic leukemia. Cancer 1974; 34: 431-437.
5. Bodey GP, Rodriguez V,Chang HY, Narboni G. Fever and
infection in leukemia patients. Cancer 1978; 41: 1610-1622.
6. Putto A, Runskanen O, Meurman O, Ekblad H,
Kurvenranta H, Mertsola J, et al. C-reactive protein in the
evaluation of febrile illeness. Arch Dis Child 1986; 61: 24-29.
7. Peltola H, Jaakkola M. C-reactive protein in early
detection of bacteremic versus viral infection in immunocompetent and
compromised children. J Pediatr 1988; 113: 641-646.
8. Gronn M, SlordahL, Skrede S, Lie SO. C-reactive
protein as an indicator of infection in immuno-suppressed child. Eur J
Pediatr 1986; 145: 18-21.
9. Aslan V, Akay OM, Gulbas Z. C-reactive protein in
the follow up and estimation of infections in acute leukemic patients.
Turk J Haematol 2003; 20: 75-80.
10. Massaro KS, Costa SF, Leone C, Chamone D.
Procalcitonin and C-reactive protein as severe systemic infection markers
in febrile neutropenic adults. BMC Infect Dis 2007; 7: 137.
11. Secmeer G, Devrim I, Kara A, Ceyhan M, Cengiz B, Kutluk T, et al.
Role of procalcitonin and CRP in differentiating a stable from a
deteriorating clinical course in pediatric febrile neutropenia. J Pediatr
Hematol Oncol 2007; 29: 107-111.
|
|
|
|